|
|
Wolfgang Dummer, Andreas G. Niethammer, Roberto Baccala, Brian R. Lawson, Norbert Wagner, Ralph A. Reisfeld, Argyrios N. Theofilopoulos
J Clin Invest. 2002;
110(2):185
doi:10.1172/JCI15175
Abstract |
Full text
| PDF

D
evelopment of tumor immunotherapies focuses on inducing autoimmune responses against tumor-associated self-antigens primarily encoded by normal, unmutated genes. We hypothesized that such responses could be elicited by T cell homeostatic proliferation in the periphery, involving expansion of T cells recognizing self-MHC/peptide ligands. Herein, we demonstrate that sublethally irradiated lymphopenic mice transfused with autologous or syngeneic T cells showed tumor growth inhibition when challenged with melanoma or colon carcinoma cells. Importantly, the antitumor response depended on homeostatic expansion of a polyclonal T cell population within lymph nodes. This response was effective even for established tumors, was characterized by CD8+ T cell–mediated tumor-specific cytotoxicity and IFN-γ production, and was associated with long-term memory. The results indicate that concomitant induction of the physiologic processes of homeostatic T cell proliferation and tumor antigen presentation in lymph nodes triggers a beneficial antitumor autoimmune response.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(47)
| Title and authors |
Publication |
Year |
In vivo delivery of interferon-α gene enhances tumor immunity and suppresses immunotolerance in reconstituted lymphopenic hosts
K Narumi, T Udagawa, A Kondoh, A Kobayashi, H Hara, Y Ikarashi, S Ohnami, F Takeshita, T Ochiya, T Okada, M Yamagishi, T Yoshida, K Aoki
|
Gene Ther
|
2011 |
Monoclonal antibody blockade of IL-2 receptor during lymphopenia selectively depletes regulatory T cells in mice and humans
D. A. Mitchell, X. Cui, R. J. Schmittling, L. Sanchez-Perez, D. J. Snyder, K. L. Congdon, G. E. Archer, A. Desjardins, A. H. Friedman, H. S. Friedman, J. E. Herndon, R. E. McLendon, D. A. Reardon, J. J. Vredenburgh, D. D. Bigner, J. H. Sampson
|
Blood
|
2011 |
Unravelling the complexity of cancer–immune system interplay
Cara K Fraser, Michael P Brown, Kerrilyn R Diener, John D Hayball
|
Expert Rev Anticancer Ther
|
2010 |
Harnessing the immune response to treat cancer
H J Steer, R A Lake, A K Nowak, B W S Robinson
|
Oncogene
|
2010 |
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
J. H. Sampson, K. D. Aldape, G. E. Archer, A. Coan, A. Desjardins, A. H. Friedman, H. S. Friedman, M. R. Gilbert, J. E. Herndon, R. E. McLendon, D. A. Mitchell, D. A. Reardon, R. Sawaya, R. Schmittling, W. Shi, J. J. Vredenburgh, D. D. Bigner, A. B. Heimberger
|
Neuro-Oncology
|
2010 |
Focus on adoptive T cell transfer trials in melanoma.
Liat Hershkovitz, Jacob Schachter, Avraham J Treves, Michal J Besser
|
Clin. Dev. Immunol.
|
2010 |
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response
G. A. Rizzuto, T. Merghoub, D. Hirschhorn-Cymerman, C. Liu, A. M. Lesokhin, D. Sahawneh, H. Zhong, K. S. Panageas, M.-A. Perales, G. Altan-Bonnet, J. D. Wolchok, A. N. Houghton
|
Journal of Experimental Medicine
|
2009 |
Regulation of T cell-dendritic cell interactions by IL-7 governs T-cell activation and homeostasis.
Manoj Saini, Claire Pearson, Benedict Seddon
|
Blood
|
2009 |
Treatment of pulmonary metastatic tumors in mice using lentiviral vector-engineered stem cells.
X Zhang, P Zhao, C Kennedy, K Chen, J Wiegand, G Washington, L Marrero, Y Cui
|
Cancer Gene Ther
|
2008 |
The nature of the lymphopenic environment dictates protective function of homeostatic-memory CD8+ T cells.
Sara E Hamilton, Stephen C Jameson
|
Proc. Natl. Acad. Sci. U.S.A.
|
2008 |
|